A brief post: well, we've reached 6 figure support in a relatively short time.

Our new target will be 1 million shares associated with this site.

Thanks for your responses. Over the next couple of posts, we'll go through those and any news that emerges. Responses have alerted me to the initiation of some coverage of Biota by US based analysts, but we need to look at the quality of those firms and not just what they are saying. I can recall many positive analyst research reports in the past, which only hurt the company when the company's actions didn't match what it told the analysts. For example, some analysts were clearly expecting a ROW lananinavir deal many years ago.

Ozbiotans are happy for an outlet for their ideas and frustrations. In fact, the lack of communication and transparency from this company ranks highly among the issues raised with me so we'll make that a priority. Other issues are the plentiful.

I'll also allow comments on the site as a trial: please keep it clean, legal and identifiable. If it works, it stays.

The share price has seen some significant selling pressure with volumes on certain days over the week, with recovery on smaller volumes.